![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
The Pharmacokinetics of Beclabuvir (BMS-791325) When Administered in Combination With Daclatasvir and Asunaprevir in Treatment-naive Patients With or Without Cirrhosis Infected With HCV Genotype 1
|
|
|
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
He B, Sims K, Chung E, Luo W-L, Pursley J, Wind-Rotolo M, LaCreta F, Bertz R, AbuTarif M
Bristol-Myers Squibb Research and Development, Princeton, NJ, USA
![EASL1.gif](../images/050515/050515-4/EASL1.gif)
![EASL2.gif](../images/050515/050515-4/EASL2.gif)
![EASL3.gif](../images/050515/050515-4/EASL3.gif)
![EASL4.gif](../images/050515/050515-4/EASL4.gif)
![EASL5.gif](../images/050515/050515-4/EASL5.gif)
![EASL6.gif](../images/050515/050515-4/EASL6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|